BioMarin Pharmaceutical

BioMarin Pharmaceutical

Develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Launch date
Employees
Market cap
€14.6b
Enterprise valuation
€14.5b (Public information from Sep 2024)
San Rafael California (HQ)
Authorizing premium user...